Company profile
Leveljump Healthcare Corp.
OTC: JMPHF · Healthcare · Medical - Diagnostics & Research
Canadian filerHQ Toronto, ONReports USD
#600 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 36
v0.1 · 5/100 weight · pillars only
↑ return on equity, return on assets · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
$14.2M
Rev growth YoY (TTM)
+6.7%
Net income (FY)
$847.2k
Employees
27
as of 2026-08-23
Market cap
$8.1M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$12.9M17.7M CAD2024
Net income$847.2k1.2M CAD2024
Operating income-$31.9k-43.7k CAD2024
Total assets$14.8M21.2M CAD2024
Liabilities$10.3M14.9M CAD2024
Equity$4.4M6.4M CAD2024
Revenue trend
FY2018 – FY2024 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Leveljump Healthcare Corp.’s revenue?
Leveljump Healthcare Corp. booked $12.9M in FY2024 revenue, growing 39% year over year — faster than most Healthcare companies we track, at a 6.5% net margin.
Peers · Healthcare
Mednow Inc.——Tonix Pharmaceuticals Holding Corp.45DRadnostix, Inc.51DSpero Therapeutics, Inc.68BLumos Diagnostics Holdings Ltd.45DNexgenRx Inc.71BKey facts
CEOMitchell Geisler
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersToronto, ON
ExchangeOTC: JMPHF
Employees27
IPO date2021-04-20
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.